Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8+T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancer

Regulatory T cells in cancer immunotherapy

(2014) Hiroyoshi Nishikawa et al.   CURRENT OPINION IN IMMUNOLOGY

HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial

(2014) Pierre-Alexandre Bart et al.   JOURNAL OF CLINICAL INVESTIGATION

PD-1 blockade induces responses by inhibiting adaptive immune resistance

(2014) Paul C. Tumeh et al.   NATURE

Expression and Immune Responses to MAGE Antigens Predict Survival in Epithelial Ovarian Cancer

(2014) Sayeema Daudi et al.   PLoS One

Location, location, location

(2014) John R Webb et al.   OncoImmunology

Therapeutic PD-1 Pathway Blockade Augments with Other Modalities of Immunotherapy T-Cell Function to Prevent Immune Decline in Ovarian Cancer

(2013) J. Duraiswamy et al.   CANCER RESEARCH

Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer

(2013) Vincent Lavoué et al.   Journal of Translational Medicine

Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy

(2012) L. van de Laar et al.   BLOOD

The immune score as a new possible approach for the classification of cancer

(2012) Jérôme Galon et al.   Journal of Translational Medicine

Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus

(2011) Vincenzo Cerullo et al.   MOLECULAR THERAPY

Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF

(2010) Anniina Koski et al.   MOLECULAR THERAPY

Viruses as vaccine vectors for infectious diseases and cancer

(2009) Simon J. Draper et al.   NATURE REVIEWS MICROBIOLOGY

Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma

(2007) Markéta Tomšová et al.   GYNECOLOGIC ONCOLOGY